Generation of endoderm‐derived human induced pluripotent stem cells from primary hepatocytes
Hua Liu, Zhaohui Ye, Yonghak Kim, Saul Sharkis, Yoon‐Young Jang – 22 April 2010 – Recent advances in induced pluripotent stem (iPS) cell research have significantly changed our perspective on regenerative medicine. Patient‐specific iPS cells have been derived not only for disease modeling but also as sources for cell replacement therapy. However, there have been insufficient data to prove that iPS cells are functionally equivalent to human embryonic stem (hES) cells or are safer than hES cells.